Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
Authors: Perugino C; Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Culver EL; Translational Gastroenterology Unit, John Radcliffe Hospital, and Nuffield Department of Medicine, University of Oxford, Oxford, UK., Khosroshahi A; Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, USA., Zhang W; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China., Della-Torre E; Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), San Raffaele Hospital, Milan, Italy., Okazaki K; Department of Internal Medicine, Kansai Medical University Kori Hospital, Osaka, Japan., Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Löhr M; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden., Schleinitz N; Département de Medecine Interne, CHU Timone, AP-HM, Aix-Marseille Université, Marseille, France., Falloon J; Horizon Therapeutics, Rockville, MD, USA., She D; Horizon Therapeutics, Rockville, MD, USA., Cimbora D; Horizon Therapeutics, Rockville, MD, USA., Stone JH; Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. jhstone@mgh.harvard.edu.; Rheumatology Unit, Massachusetts General Hospital, 55 Fruit Street, Suite Yawkey 4, Boston, MA, 02114, USA. jhstone@mgh.harvard.edu.
Source: Rheumatology and therapy [Rheumatol Ther] 2023 Dec; Vol. 10 (6), pp. 1795-1808. Date of Electronic Publication: 2023 Oct 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2198-6576
DOI:10.1007/s40744-023-00593-7